Kevin Joseph Fitzgerald, CSO & EVP, Head of Research: Alnylam Pharmaceuticals ALNY Sell · Filed 24/08/14

Trade details

Type: Insider sale
Amount: $2,610,382.54
Shares · price: 9,662 sh · $270.17 a share
Held after: 23,823 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Trade date: 24/08/12
Filed: 24/08/14
Days to filing: 2 days

Sold 28.9% of holdings

Share of holding sold: 28.9%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/07/13~24/09/11

Kevin Joseph Fitzgerald's recent trades

Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$75.3K
233 sh
$75.3K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$68K
210 sh
$68K
Filed 03/06
Traded 03/04
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$49.9K
153 sh
$49.9K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$48K
148 sh
$48K
Filed 03/06
Traded 03/05
Kevin Joseph FitzgeraldCSO & EVP, Head of Research
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$39.9K
124 sh
$39.9K
Filed 03/06
Traded 03/05

Kevin Joseph Fitzgerald, EVP — sold $2.6M of Alnylam Pharmaceuticals ALNY · 28.9% of holdings · 10b5-1 plan | Whalegun